CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
Venus Vivadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05097573
NCT05097573N/ACompleted
CompareCT.gov

Clinical Evaluation of the Efficacy of Fractional Radiofrequency for the Treatment and Reduction of Stretch Marks

Venus Concept·interventional·Posted Oct 28, 2021·Updated Sep 18, 2023

In Brief

A clinical study evaluating Venus Viva for Stretch Mark. Completed, enrolled 17 participants across 1 site.

Detailed Summary

This is a prospective, single centre, evaluator-blind study of the performance of fractional radiofrequency (RF) for the treatment and revision of stretch marks. The study will evaluate the progress of 15 subjects requesting treatment of stretch marks. The study will involve four treatments on both sides of the face with 4 week intervals between each treatment. Subjects will be followed at 12 and 16 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStretch Mark
CountriesSwitzerland
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 28, 2021
Enrollment StartMay 9, 2019
Primary CompletionAug 27, 2021
Study CompletionOct 4, 2021
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 4.7 years ago

Interventions

Venus Vivadevice

The Venus Viva™ fractional RF device has been shown in clinical studies to improve various skin conditions related to aging and alter collagen structures such as wrinkles, stretch marks, rhytids and scars. Beginning with the Baseline visit (Visit 1), subjects will receive a total of 4 treatments approximately 4 weeks apart.